When food remains in the stomach longer, the entire digestive process slows, which can lead to a sensation of fullness, reduced appetite, and altered stool consistency or frequency
The severity differential likely favors Thrive GLP-1 since it produces far weaker effects overall
However, there is a small risk of hypoglycemia (low blood sugar), especially when used with other diabetes medications like insulin or sulfonylureas
Cognitive & Neurological Support: GLP-1s may have neuroprotective effects, potentially lowering the risk of degenerative brain conditions like Alzheimers
The oxidative stress defensive factors such as FOXO1, are known to be inhibited by miR-27a, which is recognized as an oncogenic miRNA in gastric cancer (90)